МОДЕЛЬ ПО ОЦЕНКЕ РИСКА НАЛИЧИЯ ЛИПОГИПЕРТРОФИЙ У БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ, ПОЛУЧАЮЩИХ ИНСУЛИНОТЕРАПИЮ

Abstract

Nowadays lipohypertrophy remains severe insulinotherapy complication. Primary prevention is necessary for diabetic patients with pathologic areas of subcutaneous fat. Therefore, we developed the estimation risk model with good quality and high predictive value for diabetic patients who are under the treatment with insulin.

Keywords

• lipohypertrophy diagnostics
• insulinotherapy
• diabetes mellitus